Results 11 to 20 of about 124,582 (333)

Diabetes and restenosis [PDF]

Cardiovascular Diabetology, 2022
Restenosis, defined as the re-narrowing of an arterial lumen after revascularization, represents an increasingly important issue in clinical practice.
Scott Wilson, Pasquale Mone, Urna Kansakar, Stanislovas S. Jankauskas, Kwame Donkor, Ayobami Adebayo, Fahimeh Varzideh, Michael Eacobacci, Jessica Gambardella, Angela Lombardi, Gaetano Santulli   +10 more
doaj   +5 more sources

Risk factors of restenosis after paclitaxel-coated balloon treatment in symptomatic intracranial atherosclerotic disease [PDF]

Scientific Reports
Paclitaxel-coated balloon (PCB) treatment has shown promise for intracranial atherosclerotic disease (ICAD). However, studies on restenosis and its associated factors after PCB use are lacking.
Yingkun Chen, Kaiyue Dong, Yun Song, Lili Sun, Meimei Zheng, Hao Yin, Jun Zhang, Wei Wang, Yao Meng, Weili Li, Xiao He, Wei Zhao, Ju Han   +12 more
doaj   +2 more sources

Outcomes of Symptomatic Extracranial Carotid Artery Stenting in Octogenarians: A Single-Center Retrospective Study on Restenosis, Risk Factors, and Complications [PDF]

Medicina
Objectives: This study aimed to evaluate the 6-month restenosis rate, risk factors, and complications following carotid artery stenting (CAS) in patients aged 80 years and older, assessing the efficacy and safety of CAS in this population.
Özgür Zülfükar Ertuğrul, Fırat Karaaslan, Reşit Yılmaz, Mehmet Cudi Tuncer   +3 more
doaj   +2 more sources

Angiographic Patterns of In-Stent Restenosis

Circulation, 1999
BACKGROUND The angiographic presentation of in-stent restenosis (ISR) may convey prognostic information on subsequent target vessel revascularizations (TLR).
Roxana Mehran, George Dangas, Alexandre Abizaid, Gary S. Mintz, Alexandra J. Lansky, Lowell F. Satler, Augusto D. Pichard, Kenneth M. Kent, Gregg W. Stone, Martin B. Leon   +9 more
openalex   +2 more sources

Mitral Valvotomy and Restenosis [PDF]

BMJ, 1960
D. E. L. Wilcken
openalex   +5 more sources

Stent-induced hypersensitivity leading to refractory in-stent restenosis: a case report [PDF]

Journal of Medical Case Reports
Background Even in the era of new-generation drug-eluting stents, in-stent restenosis remains a common and challenging problem of percutaneous coronary intervention.
Menghuai Ma, Jiong Tang
doaj   +2 more sources

THE CARDIOGRAM OF MITRAL RESTENOSIS [PDF]

Heart, 1963
Hala Mourad Demerdash, J. F. Goodwin
openalex   +5 more sources

Effect of Epicardial Adipose Tissue on In-stent Restenosis after Percutaneous Coronary Intervention: a Review [PDF]

Zhongguo quanke yixue, 2023
As a major treatment for coronary artery disease, percutaneous coronary intervention (PCI) effectively enhances the survival rate of patients. However, the post-PCI in-stent restenosis has become a new cardiovascular problem that is difficult to solve ...
AN Jingjing, WANG Xiaojuan, DENG Aiyun
doaj   +1 more source

Reducing In-Stent Restenosis [PDF]

Journal of the American College of Cardiology, 2015
Background: Drug-eluting stents reduce the incidence of in-stent restenosis, but they result in delayed arterial healing and are associated with a chronic inflammatory response and hypersensitivity reactions. Identifying novel interventions to enhance
Robert A. McDonald, Crawford A. Halliday, Ashley M. Miller, L. Diver, Rachel S. Dakin, Jennifer Montgomery, Martin W. McBride, Simon Kennedy, John D. McClure, Keith E. Robertson, Gillian Douglas, Keith M. Channon, Keith G. Oldroyd, Andrew H. Baker   +13 more
semanticscholar   +3 more sources

Management of in-stent restenosis.

EuroIntervention, 2022
In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI procedures performed in current clinical practice.
F. Alfonso, J. Coughlan, D. Giacoppo, A. Kastrati, R. Byrne   +4 more
semanticscholar   +1 more source